The<unk>  <unk>  is a clinical trial from the early 2000s designed determine how the drug<unk>  compares with the drug<unk>  in reducing the incidence of breast cancer in women who are at increased risk of the disease.
Study of Tamoxifen and Raloxifene
Early versus Late Intervention Trial with Estradiol
Comparison of bicalutamide with other antiandrogens
Preventive mastectomy
Estrogen deprivation therapy
Neoadjuvant therapy
Androgen deprivation therapy
Maximum androgen blockade